TENAX THERAPEUTICS, INC.
Clinical-stage pharma company developing cardiovascular and pulmonary therapies.
TENX | US
Overview
Corporate Details
- ISIN(s):
- US88032L2097
- LEI:
- Country:
- United States of America
- Address:
- 101 GLEN LENNOX DRIVE, 27517 CHAPEL HILL
- Website:
- http://www.tenaxthera.com/
- Sector:
- Manufacturing
Description
Tenax Therapeutics, Inc. is a clinical-stage pharmaceutical company focused on developing and commercializing novel therapies for cardiovascular and pulmonary diseases. The company's primary drug candidate is TNX-103, an oral formulation of levosimendan, for the treatment of heart failure. The intravenous form of levosimendan is already approved in numerous countries for acute decompensated heart failure, providing an established safety profile. Additionally, Tenax is developing a formulation of imatinib mesylate, a kinase inhibitor, for the treatment of pulmonary arterial hypertension (PAH). The company's development strategy is guided by clinical insights into cardiopulmonary disorders and is led by a management team with extensive experience in the field.
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
| Date | Filing | Language | Type / Size | Actions | |
|---|---|---|---|---|---|
| 2025-11-21 00:38 |
PRIMARY DOCUMENT
|
English | ZIP • 8.7 KB | ||
| 2025-11-21 00:16 |
PRIMARY DOCUMENT
|
English | ZIP • 7.9 KB | ||
| 2025-11-20 01:01 |
PRIMARY DOCUMENT
|
English | ZIP • 7.5 KB | ||
| 2025-11-20 00:43 |
PRIMARY DOCUMENT
|
English | ZIP • 7.9 KB | ||
| 2025-11-14 18:38 | English | ZIP • 11.3 KB | |||
| 2025-11-14 17:10 | English | ZIP • 9.1 KB | |||
| 2025-11-14 17:07 | English | ZIP • 13.2 KB | |||
| 2025-11-12 17:40 |
10-Q
|
English | ZIP • 887.3 KB | ||
| 2025-11-12 17:38 |
FORM 8-K
|
English | ZIP • 107.7 KB | ||
| 2025-11-05 22:24 | English | ZIP • 11.7 KB | |||
| 2025-10-29 22:29 | English | ZIP • 11.9 KB | |||
| 2025-10-07 22:15 | English | ZIP • 215.6 KB | |||
| 2025-10-02 23:04 | English | ZIP • 12.0 KB | |||
| 2025-09-16 14:10 |
FORM 8-K
|
English | ZIP • 82.5 KB | ||
| 2025-09-09 14:02 |
FORM 8-K
|
English | ZIP • 83.2 KB |
Automate Your Workflow. Get a real-time feed of all TENAX THERAPEUTICS, INC. filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
Unlock Full Financials for TENAX THERAPEUTICS, INC.
This data is available as part of our premium data solutions. Contact our team for access.
Need More History? Access decades of standardized financials for TENAX THERAPEUTICS, INC. via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| No insider transactions recorded for this company. | |||||
Peer Companies
